References
- Bizzarri, N., et al., 2021. Peritoneal HPV-DNA test in cervical cancer (PIONEER study): a proof of concept. International Journal of Cancer, 148 (5), 1197–1207.
- Chen, R.X., et al., 2019. Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. European Review for Medical and Pharmacological Sciences, 23, 8771–8778.
- Chi, B.J., et al., 2019. Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance. Neoplasma, 66 (2), 197–202.
- Dasari, S., Wudayagiri, R. and Valluru, L., 2015. Cervical cancer: biomarkers for diagnosis and treatment. Clinica Chimica Acta; International Journal of Clinical Chemistry, 445, 7–11.
- Di Donna, M.C., et al., 2022. Conventional laparoscopy versus robotic-assisted aortic lymph-nodal staging for locally advanced cervical cancer: a systematic review and meta-analysis. J Clin Med, 11, 3332.
- Fan, C.M., et al., 2019. circMAN1A2 could serve as a novel serum biomarker for malignant tumors. Cancer Science, 110 (7), 2180–2188.
- Flahault, A., Cadilhac, M. and Thomas, G., 2005. Sample size calculation should be performed for design accuracy in diagnostic test studies. Journal of Clinical Epidemiology, 58 (8), 859–862.
- Gao, R., et al., 2021. Inhibition of circular RNA_0000285 prevents cell proliferation and induces apoptosis in thyroid cancer by sponging microRNA-654-3p. Oncology Letters, 22 (3), 673.
- Guo, L., et al., 2022. Serum hsa_circ_0079480 is a novel prognostic marker for acute myeloid leukemia. Journal of Clinical Laboratory Analysis, 36 (4), e24337.
- Hill, E.K., 2020. Updates in cervical cancer treatment. Clinical Obstetrics and Gynecology, 63 (1), 3–11.
- Hu, Z. and Ma, D., 2018. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Medicine, 7 (10), 5217–5236.
- Huang, J., et al., 2022. Hsa_circ_0000285 knockdown inhibits the progression of hepatocellular carcinoma by sponging miR-582-3p to regulate CCNB2 expression. Human & Experimental Toxicology, 41, 9603271221115400.
- Koh, W.J., et al., 2019. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 17, 64–84.
- Kristensen, L.S., et al., 2019. The biogenesis, biology and characterization of circular RNAs. Nature Reviews. Genetics, 20 (11), 675–691.
- Li, X., et al., 2020. Identification of Hsa_circ_0104824 as a potential biomarkers for breast cancer. Technology in Cancer Research & Treatment, 19, 1533033820960745.
- Liu, F., Duan, C. and Han, Y., 2022. Circular RNA hsa_circ_0000285 regulates the microRNA-599/G-protein subunit gamma 12 (miR-599/GNG12) axis to promote glioma progression. Journal of Clinical Laboratory Analysis, 36 (3), e24207.
- Long, Z., et al., 2020. Circ_0000285 regulates proliferation, migration, invasion and apoptosis of osteosarcoma by miR-409-3p/IGFBP3 axis. Cancer Cell International, 20, 481.
- Patop, I. L., Wüst, S. and Kadener, S., 2019. Past, present, and future of circRNAs. European Molecular Biology OrganizationJournal, 38 (16), e100836.
- Peng, Z., et al., 2021. Circulating circTOLLIP serves as a diagnostic biomarker for liquid biopsy in non-small cell lung cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry, 523, 415–422.
- Saleh, M., et al., 2020. Cervical cancer: 2018 revised international federation of gynecology and obstetrics staging system and the role of imaging. American Journal of Roentgenology, 214 (5), 1182–1195.
- Shen, B., et al., 2019. Circular RNAs: an emerging landscape in tumor metastasis. American Journal of Cancer Research, 9, 630–643.
- Shuai, M., et al., 2018. Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity. Oncology Letters, 16 (5), 6495–6501.
- Siegel, R.L., et al., 2022. Cancer statistics, 2022. CA: a Cancer Journal for Clinicians, 72 (1), 7–33.
- Sivars, L., et al., 2022. Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer. Gynecologic Oncology, 167 (1), 107–114.
- Sole, C., Mentxaka, G. and Lawrie, C.H., 2021. The use of circRNAs as biomarkers of cancer. Methods in Molecular Biology), 2348, 307–341.
- Tang, X., et al., 2020. Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer. Cell Death & Disease, 11 (8), 625.
- Wang, X., et al., 2022. Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR-1278. Journal of Clinical Laboratory Analysis, 36 (6), e24475.
- Wang, S., et al., 2021. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Molecular Cancer, 20 (1), 13.
- Yin, G., et al., 2020. Circulating circRNA has_circ_0141633 serves as a potential biomarker for gastric cancer. Clinical Laboratory, 66, 191234.
- Zhang, Z., et al., 2020. Hsa_circ_0000285 functions as a competitive endogenous RNA to promote osteosarcoma progression by sponging hsa-miRNA-599. Gene Therapy, 27, 186–195.
- Zhang, S., Xu, Y. and Zheng, Q., 2022. circRNA_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microRNA-654-3p. Bioengineered, 13, 5251–5261.
- Zhang, Z., Yang, T. and Xiao, J., 2018. Circular RNAs: promising biomarkers for human diseases. EBioMedicine, 34, 267–274.
- Zhang, W. and Zhang, S., 2020. Downregulation of circRNA_0000285 suppresses cervical cancer development by regulating miR197-3p-ELK1 axis. Cancer Management and Research, 12, 8663–8674.
- Zhou, C., Li, R. and Mi, W., 2020. circ_0067934: a potential biomarker and therapeutic target for hepatocellular carcinoma. Annals of Clinical and Laboratory Science, 50, 734–738.